WJA
BLUE

Williams Jones & Associates’s bluebird bio BLUE Stock Holding History

Williams Jones & Associates’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-452
Closed -$253K – 404
2016
Q2 		$253K Sell
452
-384
-46% -$217K 0.01% 336
2016
Q1 		$460K Sell
836
-716
-46% -$440K 0.02% 214
2015
Q4 		$1.29M Sell
1,552
-2,585
-62% -$2.58M 0.06% 150
2015
Q3 		$4.58M Sell
4,137
-738
-15% -$1.35M 0.21% 102
2015
Q2 		$10.6M Sell
4,875
-142
-3% -$289K 0.41% 68
2015
Q1 		$7.85M Buy
5,017
+3,856
+332% +$5.09M 0.32% 88
2014
Q4 		$1.38M Buy
+1,161
New +$776K 0.06% 173

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Williams Jones & Associates's BLUE Position: Q3 2016 in Review

Williams Jones & Associates sold out of bluebird bio (BLUE) in Q3 2016, closing a stake of 452 shares — an estimated $253K sold.

Williams Jones & Associates first reported a position in BLUE in Q4 2014 and held it in 7 quarters. The position peaked at $10.6M in Q2 2015. 200 funds tracked by Wall St. Rank hold BLUE as of Q3 2016.

  • Williams Jones & Associates reported no remaining bluebird bio position as of Q3 2016 after selling out during the quarter.
  • Williams Jones & Associates sold 452 bluebird bio shares in Q3 2016, an estimated $253K.
  • Williams Jones & Associates first reported a position in bluebird bio in Q4 2014 and held it in 7 quarters.
  • Williams Jones & Associates's bluebird bio position peaked at $10.6M in Q2 2015.
  • 200 funds tracked by Wall St. Rank held bluebird bio as of Q3 2016.

Based on Williams Jones & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.